On June 14, we demonstrated and explained the Anyfusion Cylinder pump and Anyfusion ACPi system to oncologists, pharmacy directors, nursing and purchasing directors, and local healthcare officials at Virgen del Rocio university Hospital in Sevilla, Southwest Spain, the fifth largest university hospital in Spain. The Anyfusion cylinder pump is not available for additional purchase due to the high volume of existing products due to the corona pandemic, but the Anyfusion ACPi system is needed immediately by all medical staff, including government officials, so we were asked to supply it immediately with quick manual certification. Most countries in Europe have a public procurement system based on a welfare system, where the government purchases and supplies all medical equipment, supplies, and medicines, so we learned the reason why the government officials attended. The government officials gave us their business cards, recommending that we present our products at a meeting of all European public procurement officials next September. If we were selected as a presenter at the meeting, we would be selected as a public procurement item for all of Europe, and the ACPi system was recommended as an urgently needed equipment and gave us ideas. As the daily dispensing volume of anti-cancer drugs in the above hospital is about 400, Anyfusion ACPi system has three functions in one equipment, including dispensing safety, hourly dispensing volume, TPN dispensing, and PCA balloon filling, and its wide dispensing range and appropriate price-performance ratio made all the medical staff as well as procurement officials and government officials quite satisfied and identified high needs for purchase. We will do our best to sell it quickly, aiming for rapid certification by early 2024. If it is used in this hospital, it is said that it is only a matter of time before it is expanded to other hospitals in Spain. It's the same situation in Italy, the next country we visited. Both countries, which have developed anti-cancer drug dispensing robots, considered but did not introduce pharmacy robots due to their low practicality and cost-effectiveness, but were satisfied with the Anyfuion ACPi system as an optimized model equipment.  The Anyfusion ACpi system for dispensing is an optimized model for the medical system in most countries except the United States, such as Europe, Japan, Australia, New Zealand, and Canada, and the model from dispensing to injection with CAM was identified as a suitable model for the US market.

Luctormedical's introduction to the US buyer was that it was difficult to have a real buyer meeting due to the lack of FDA certification, and the same as in Europe, it was expected to be a difficult business due to strong resistance based on the solid foundation of major companies supplying existing products.  In Europe and the U.S., the Anyfusion ACPi system is the equipment that is needed immediately, and we proposed a plan to spread it as a competitive advantage by purchasing and using the pump by using the Anyfusion cylinder pump for injection after dispensing with the ACPi system. The Anyfusion ACPi system, which is a sterile anti-cancer manufacturing equipment, is expected to become a non-toxic zone in the European and American markets. The FDA has selected Anyfusion cylinder pump with guaranteed safety as a STeP that needs to be quickly replaced, but existing companies are not willing to accept it easily as a matter of corporate success or failure and seem to form an active defense shield. We believe that it is necessary to negotiate directly with the FDA if possible after FDA approval. FDA certification is progressing well with fast track.

After the product description in Spain and Italy, it is said that the web hosting company experienced the first time that the homepage was hacked at more than 8~9 megabytes per hour, causing the homepage to crash dozens of times a day, including large companies. They decided to change their solution and increase their security. If Anyfusion is active in the market, it is expected that the products of pharmaceutical infusion pumps, anti-cancer robotics companies, and CSTD product suppliers will become useless. It seems that indiscriminate hacking is being done to prevent the emergence of Anyfusion. In short, it's a war.

Thank you.